%0 Journal Article
%A Wu, Wendy Yi-Ying
%A Haider, Zahra
%A Feng, Xiaoshuang
%A Heath, Alicia K
%A Tjønneland, Anne
%A Agudo, Antonio
%A Masala, Giovanna
%A Robbins, Hilary A
%A Huerta, Jose-Maria
%A Guevara, Marcela
%A Schulze, Matthias B
%A Rodriguez-Barranco, Miguel
%A Vineis, Paolo
%A Tumino, Rosario
%A Kaaks, Rudolf
%A Fortner, Renée T
%A Sieri, Sabina
%A Panico, Salvatore
%A Nøst, Therese Haugdahl
%A Sandanger, Torkjel M
%A Braaten, Tonje
%A Johansson, Mattias
%A Melin, Beatrice
%A Johansson, Mikael
%T Assessment of the EarlyCDT-Lung test as an early biomarker of lung cancer in ever-smokers: A retrospective nested case-control study in two prospective cohorts.
%D 2022
%U http://hdl.handle.net/10668/22117
%X The EarlyCDT-Lung test is a blood-based autoantibody assay intended to identify high-risk individuals for low-dose computed tomography lung cancer screening. However, there is a paucity of evidence on the performance of the EarlyCDT-Lung test in ever-smokers. We conducted a nested case-control study within two prospective cohorts to evaluate the risk-discriminatory performance of the EarlyCDT-Lung test using prediagnostic blood samples from 154 future lung cancer cases and 154 matched controls. Cases were selected from those who had ever smoked and had a prediagnostic blood sample
%K EarlyCDT-Lung test
%K biomarkers
%K lung cancer
%K prediagnostic samples
%~